Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Yu-Yan Cheung

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of the American Society of Nephrology : JASN|January 21, 2026
Authors' Reply: Proteomic CKD Prediction in Type 2 Diabetes: Underexplored Limitations and Translational GapsChloe Yu-Yan Cheung, Chi-Ho Lee, Karen Siu-Ling Lam, et al.
World Journal of Diabetes|April 16, 2025
Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center studyKam-Ching Ku, Junda Zhong, Erfei Song, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2023
Circulating thrombospondin-2 level for identifying individuals with rapidly declining kidney function trajectory in type 2 diabetes: a prospective study of the Hong Kong West Diabetes RegistryChi-Ho Lee, David Tak-Wai Lui, Chloe Yu-Yan Cheung, et al.
Journal of the American Heart Association|June 8, 2017
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes MellitusChi Ho Lee, Yu Cho Woo, Wing Sun Chow, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2026
A Five-Plasma Protein-Based Algorithm for Predicting Incident CKD in Type 2 DiabetesChenxin Xu, Chloe Yu-Yan Cheung, Junda Zhong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2023
Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic RetinopathyChi-Ho Lee, David Tak-Wai Lui, Chloe Yu-Yan Cheung, et al.
Diabetes Care|June 29, 2021
Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 DiabetesChi-Ho Lee, Wai-Kay Seto, David Tak-Wai Lui, et al.
Clinical Endocrinology|December 21, 2023
Serum thrombospondin-2 level changes with liver stiffness improvement in patients with type 2 diabetesJimmy Ho Cheung Mak, David Tak-Wai Lui, Carol Ho-Yi Fong, et al.
Journal of Clinical Biochemistry and Nutrition|November 25, 2024
General and sex-specific effects of vitamin D against atrial fibrillation and young-onset ischemic stroke: a Mendelian randomization seriesYap-Hang Chan, Jie V Zhao, C Mary Schooling, et al.
Diabetes, Obesity & Metabolism|November 5, 2024
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world studyChi-Ho Lee, David Tak-Wai Lui, Lung-Yi Mak, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|January 21, 2026
Authors' Reply: Proteomic CKD Prediction in Type 2 Diabetes: Underexplored Limitations and Translational GapsChloe Yu-Yan Cheung, Chi-Ho Lee, Karen Siu-Ling Lam, et al.
World Journal of Diabetes|April 16, 2025
Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center studyKam-Ching Ku, Junda Zhong, Erfei Song, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2023
Circulating thrombospondin-2 level for identifying individuals with rapidly declining kidney function trajectory in type 2 diabetes: a prospective study of the Hong Kong West Diabetes RegistryChi-Ho Lee, David Tak-Wai Lui, Chloe Yu-Yan Cheung, et al.
Journal of the American Heart Association|June 8, 2017
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes MellitusChi Ho Lee, Yu Cho Woo, Wing Sun Chow, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2026
A Five-Plasma Protein-Based Algorithm for Predicting Incident CKD in Type 2 DiabetesChenxin Xu, Chloe Yu-Yan Cheung, Junda Zhong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2023
Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic RetinopathyChi-Ho Lee, David Tak-Wai Lui, Chloe Yu-Yan Cheung, et al.
Diabetes Care|June 29, 2021
Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 DiabetesChi-Ho Lee, Wai-Kay Seto, David Tak-Wai Lui, et al.
Clinical Endocrinology|December 21, 2023
Serum thrombospondin-2 level changes with liver stiffness improvement in patients with type 2 diabetesJimmy Ho Cheung Mak, David Tak-Wai Lui, Carol Ho-Yi Fong, et al.
Journal of Clinical Biochemistry and Nutrition|November 25, 2024
General and sex-specific effects of vitamin D against atrial fibrillation and young-onset ischemic stroke: a Mendelian randomization seriesYap-Hang Chan, Jie V Zhao, C Mary Schooling, et al.
Diabetes, Obesity & Metabolism|November 5, 2024
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world studyChi-Ho Lee, David Tak-Wai Lui, Lung-Yi Mak, et al.
Pageof 2